The space is clean, serene and beautiful
Vettore L, Westbrook RL, Tennant DA
Alternative GLP-1 options to consider If the Boothwyn findings concern you, exploring alternative GLP-1 compounds and delivery methods is worthwhile
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for type 2 diabetes management and, more recently, for chronic weight management
Common Side Effects Reported Across Phase 2 trials, participants experienced dose-dependent GI symptoms that are characteristic of GLP-1 receptor agonists: Nausea most frequent, especially during dose escalation Vomiting typically mild to moderate, subsiding with continued use Diarrhea and constipation fluctuating depending on individual tolerance Abdominal discomfort transient and often improved over time Dose-Response Relationship At lower doses (14 mg weekly), side effects were generally mild and manageable, though some participants still reported early GI symptoms
Affiliation: B